Davletshina R.; Ivanov A.; Evtugyn G.
(2019)
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim The acetylcholinesterase (AChE) biosensor has been developed for the determination of reversible inhibitors applied in the Alzheimer's disease therapy, i. e., Huperzine ...